Manja slova Veća slova RSS

Ask the Government

• Ask the Government

2340 doses of Pfizer-BioNTech vaccine arrives in Montenegro, the first batch intended for priority groups

2340 doses of Pfizer-BioNTech vaccine arrives in Montenegro, the first batch intended for priority groups
Published date 04.05.2021 10:30 | Author PR Service

Ispis Print


The batch of 2340 doses of Pfizer-BioNTech vaccine will arrive today in Montenegro. This is the first delivery of a total of 42,000 doses of this vaccine intended for Montenegro, which will arrive by the end of August. Vaccine deliveries are funded by a 70m-euro financial assistance package adopted by the European Commission in December 2020 to help Western Balkan partners cover the cost of buying vaccines. The distribution of vaccines, whose purchase is financed by the EU, was made possible by Austria by concluding legal arrangements with the manufacturer and partners from the Western Balkans.

The first batch is intended for priority groups, which include health workers and people with conditions that are considered clinically extremely vulnerable: recipients of solid organ transplants; persons with certain types of malignant neoplasms; people with malignant neoplasms undergoing active chemotherapy; people with malignant lung neoplasms who are on radical radiotherapy; people with malignant neoplasms of the blood or bone marrow such as leukemia, lymphoma or myeloma who are in any stage of treatment; people undergoing immunotherapy or other types of continuous antibody treatment to treat a malignant neoplasm; people who have other forms of targeted treatment for malignant neoplasms, which can affect the immune system, people who have had a bone marrow or stem cell transplant in the last six months or who are still taking/receiving immunosuppressive therapy; people with severe respiratory conditions, including cystic fibrosis, severe asthma, and severe chronic obstructive pulmonary disease (COPD); people with rare diseases that significantly increase the risk of infections (such as severe combined immunodeficiency (SCID), homozygous sickle cell disease); people on immunosuppressive therapy that is strong enough to significantly increase the risk of infection; spleen problems, for example splenectomy; adults with Down syndrome; adults on dialysis or with chronic kidney disease (stage 5); pregnant women with significant heart disease, congenital or acquired as well as teenagers aged 16 to 18 who have some chronic disease.

Due to the specific way of storage and administration, vaccines from the first batch will be available in health centres in the following municipalities:

- Primary Health Care Centre Podgorica (Military Medical Centre from 15:00) - vulnerable groups from Podgorica, Tuzi, Danilovgrad and Cetinje;
- Clinical Centre of Montenegro, Public Health Institute - health workers from Podgorica, Tuzi, Danilovgrad and Cetinje;
- Primary Health Care Centre Bar - vulnerable groups and health workers from the municipalities of Bar and Ulcinj;
- Primary Health Care Centre Kotor - vulnerable groups and health workers from the municipalities of Kotor, Budva;
- Primary Health Care Centre Nikšić - vulnerable groups and health workers from the municipalities of Nikšić, Plužine and Šavnik;
- Primary Health Care Centre Berane - vulnerable groups and health workers from the municipalities of Berane, Rožaje, Plav, Petnjica, Gusinje, Andrijevica;
- Primary Health Care Centre Herceg Novi - vulnerable groups and health workers from the municipalities of Herceg Novi and Tivat;
- Primary Health Care Centre Bijelo Polje - vulnerable groups and health workers from the municipalities of Bijelo Polje, Kolašin and Mojkovac;
- Primary Health Care Centre Pljevlja - vulnerable groups and health workers from the municipalities of Pljevlja and Žabljak.

When these specific groups are covered by the Pfizer-BioNTech vaccine, all additional doses that arrive in Montenegro will be intended for the general population.